Abstract: A suction nozzle assembly used in manufacture for the gentlest handling of delicate components such as a camera lens includes a suction nozzle rod and a suction nozzle member. The suction nozzle rod includes a first through hole. The suction nozzle member includes a main body and a suction nozzle located on both sides of the main body. The main body includes a second through hole connected to the first through hole, and a third through hole connected to the second through hole. The suction nozzle includes at least one suction nozzle hole connected to the third through hole. The disclosure also provides a suction device having the suction nozzle assembly.

Abstract: Embodiments of the present application provide a battery cell, a battery, a power consumption device, and a battery cell manufacturing method and device. The battery cell includes: a shell, including a first wall provided with a medium injection hole; an electrode assembly, disposed inside the shell; and an insulating member, disposed between the first wall and the electrode assembly to insulate and isolate the first wall and the electrode assembly, where a guide structure is disposed on a side, facing the first wall, of the insulating member, and the guide structure is configured to guide a medium injected from the medium injection hole to an edge of the insulating member, so that the medium enters the interior of the battery cell from the edge of the insulating member.

Abstract: The present disclosure relates to a spike event decision-making device, method, chip, and electronic device to eliminate inherent delays of an output spike event of the neuromorphic chip when reading decisions. The spike event decision-making device includes a first counting module configured to count a number of input spike events of the spiking neural network, a second counting module configured to count some or all of the output spike events of the spiking neural network; and a decision-making module configured to generate a decision-making result according to numbers of spike events fired by neurons in an output layer of the spiking neural network when the number counted by the first counting module reaches a first predetermined value, or when the total count counted by the second counting module reaches a second predetermined value.

Abstract: The present invention relates to heterodimeric Relaxin fusion polypeptides, in particular to heterodimeric Relaxin 2 fusion polypeptides and uses thereof. Thus, the invention provides Relaxin fusion polypeptides, nucleic acid molecules, vectors, host cells, pharmaceutical compositions and kits comprising the same and uses of the same including methods of treatment. The polypeptides and compositions of the invention may be useful, in particular, in the treatment of cardiovascular diseases, for example for the treatment of heart failure.

Abstract: Described herein are stable pharmaceutical formulations for bioactive agents, including macromolecular bioactive agents such as polynucleotides and polypeptides. Also provided are medicaments and treatments using the pharmaceutical formulations described herein, as well as kits and methods of treating, preventing or managing a disease or disorder using the pharmaceutical formulations described herein.

Abstract: The present invention relates to heterodimeric Relaxin fusion polypeptides, in particular to heterodimeric Relaxin 2 fusion polypeptides and uses thereof. Thus, the invention provides Relaxin fusion polypeptides, nucleic acid molecules, vectors, host cells, pharmaceutical compositions and kits comprising the same and uses of the same including methods of treatment. The polypeptides and compositions of the invention may be useful, in particular, in the treatment of cardiovascular diseases, for example for the treatment of heart failure.

Abstract: The present invention relates to heterodimeric Relaxin fusion polypeptides, in particular to heterodimeric Relaxin 2 fusion polypeptides and uses thereof. Thus, the invention provides Relaxin fusion polypeptides, nucleic acid molecules, vectors, host cells, pharmaceutical compositions and kits comprising the same and uses of the same including methods of treatment. The polypeptides and compositions of the invention may be useful, in particular, in the treatment of cardiovascular diseases, for example for the treatment of heart failure.

Abstract: Provided are picture encoding and decoding methods and apparatuses, and a picture encoding and decoding system. The picture encoding method includes: determining an adjustment factor according to pixel sampling values of a video picture; converting the video picture according to the adjustment factor, and encoding the converted video picture; and writing the adjustment factor into a bitstream obtained by encoding the converted video picture.

Abstract: Provided are picture encoding and decoding methods and apparatuses, and a picture encoding and decoding system. The picture encoding method includes: determining an adjustment factor according to pixel sampling values of a video picture; converting the video picture according to the adjustment factor, and encoding the converted video picture; and writing the adjustment factor into a bitstream obtained by encoding the converted video picture.